meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID-19

results overview
latest studies
standard queries
browse treatments
mapping
NMA
methods

COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
secondary prevention

see more...

click on circles to display study description...

Kumar, 2021 CTRI/2020/05/024959

itolizumab (n=22) vs. standard of care (n=10)

randomized controlled trial high risk of bias

Studied treatment

itolizumab

Control treatment

standard care

Patients

COVID-19 severe or critically

Method

open-label

Remark

powered by vis.js Network